Roka Bioscience to Present at the 29th Annual Roth Conference

Friday, March 10, 2017 General News
Email Print This Page Comment

WARREN, N.J., March 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ:ROKA), a molecular diagnostics company focused

on providing advanced testing solutions for the detection of foodborne pathogens,  today announced that Mary Duseau, CEO will present at the 29th Annual Roth Conference on March 14
at 8:00am PT. The conference will be held at The Ritz –Carlton, Dana Point CA.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies.  For more information, visit http://rokabio.com.

Investor Contact:Roka Bioscience, Inc.ir@rokabio.com855-ROKABIO (855-765-2246)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-29th-annual-roth-conference-300421537.html

SOURCE Roka Bioscience, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook